An open prospective multicentre randomised study of haemorrhoid excision (Milligan-Morgan) and stapled anopexy (Longo) for the treatment of prolapsing haemorrhoids
| ISRCTN | ISRCTN68315343 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN68315343 |
| Protocol serial number | N/A |
| Sponsor | Ethicon Endo-Surgery (Germany) |
| Funder | Ethicon Endo-Surgery Europe (Germany) |
- Submission date
- 18/11/2007
- Registration date
- 21/02/2008
- Last edited
- 08/08/2011
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Karolinska Institute
Department of Surgical Gastroenterology
Karolinska University Hospital Huddinge
Stockholm
14186
Sweden
| per-olof.nystrom@karolinska.se |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Multi-centre randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study acronym | STOPP (Stapled or Open Pile Procedure) trial |
| Study objectives | To prove that stapled anopexy produces better or at least similar clinical outcome compared to the Milligan-Morgan operation. The outcomes assessed are: 1. Self-reported symptom reduction (submitted by the patients) 2. Anatomical normalisation (submitted by the surgeons) |
| Ethics approval(s) | Ethics approval was obtained for each participating Hospital. Main approval was granted by the Ethics Committee of Linkoping University (Sweden) on the 8th October 1999 (ref: 99099). |
| Health condition(s) or problem(s) studied | Haemorrhoid prolapse |
| Intervention | Half of the participants were randomised to the intervention group and another half to the control group. Intervention group: Stapled anopexy Control group: Conventional diathermy haemorrhoidecomy |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Self-reported symptom reduction, assessed by a symptom questionnaire filled by the patients pre-treatment and at one year after surgery |
| Key secondary outcome measure(s) |
1. Operation time |
| Completion date | 31/12/2001 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | All |
| Target sample size at registration | 200 |
| Key inclusion criteria | 1. Haemorrhoid grade III or IV 2. Prolapse of one or more haemorrhoids on examination, together with parts of the anal canal, or a prolapse that can be provoked by digital traction on the (reduced) haemorrhoid |
| Key exclusion criteria | 1. Retained anal canal 2. No consistent history of haemorrhoid prolapse 3. A history of severe anal fistula (high fistula) or a ruptured anal sphincter (obstetric injury) will usually disqualify the patient from participation in this trial |
| Date of first enrolment | 01/05/1999 |
| Date of final enrolment | 31/12/2001 |
Locations
Countries of recruitment
- United Kingdom
- Denmark
- Sweden
Study participating centre
14186
Sweden
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/02/2010 | Yes | No |